A Pim kinase inhibitor, please

Francis Giles

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

Hammerman and colleagues have shown that the Pim-2 kinase is required to confer rapamycin resistance in hematopoietic cells, thus providing a strong rationale for the development of Pim kinase inhibitors as potential therapeutic agents in hematologic malignancies.

Original languageEnglish (US)
Pages (from-to)4158-4159
Number of pages2
JournalBlood
Volume105
Issue number11
DOIs
StatePublished - Jun 1 2005

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'A Pim kinase inhibitor, please'. Together they form a unique fingerprint.

  • Cite this